Taiwans United Biomedical reappliesforvaccineauthorization
UB-612previously rejected because it did not match up to AstraZeneca vaccine
Aug. 27, 2021 18:04
UB-612previously rejected because it did not match up to AstraZeneca vaccine
UB-612previously rejected because it did not match up to AstraZeneca vaccine
UB-612previously rejected because it did not match up to AstraZeneca vaccine
UBI is second Taiwanese company to develop own vaccine
UBI is second Taiwanese company to develop own vaccine
UBI's vaccine shows positive results in efficacy, no serious adverse reactions in trials
UBI's vaccine shows positive results in efficacy, no serious adverse reactions in trials